We believe that no other biomedical discipline has greater implications for human health than immunology. By unraveling the complexities of the immune system, LJI researchers are directly tackling an extraordinarily diverse array of diseases, such as asthma, cancer, CoVID-19, type 1 diabetes, Parkinson’s, and many others.
At La Jolla Institute for Immunology, every day, our discoveries move the world closer to Life Without Disease.
La Jolla Institute is home to three research centers that focus the efforts of collaborative groups of researchers on defined areas of inquiry, to accelerate progress toward the development of new treatments and vaccines to prevent and cure autoimmune conditions, cancer and infectious disease.
Research into different autoimmune diseases can inform the development of new treatments that teach the immune system to tolerate the body’s own cells.
The Center is at the forefront of exploring new and sometimes unexpected avenues for novel immune-based cancer treatments.
Amid the COVID-19 pandemic, LJI infectious disease experts quickly mobilized a task force to respond to the current crisis.
As she advances global health, LJI Professor Sujan Shresta takes on three new research projects to support equity for scientists in South and Southeast Asia
In addition to developing the antibodies for use in diagnostic applications based on N protein-specific antibodies, Leinco will make these antibodies commercially available as part of their extensive catalogue of research tools.
People who have already been sick with Covid-19 should still be vaccinated, experts say, but they may experience intense side effects even after one dose.
Speaker: Yanal Ghosheh, Ph.D.
La Jolla Institute for Immunology
Host: Klaus Ley, Ph.D.
Speaker: Abhijit Chakraborty, Ph.D.
La Jolla Institute for Immunology
Host: Ferhat Ay, Ph.D.